Inhibition of ROMK potassium channel by syntaxin 1A.
Sun
Tie-Jun
TJ
Department of Medicine, Division of Nephrology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-8856, USA.
Zeng
Wei-Zhong
WZ
Huang
Chou-Long
CL
D000818:Animals; D000954:Antigens, Surface / Q000494:pharmacology*; D001905:Botulinum Toxins / Q000494:pharmacology; D019274:Botulinum Toxins, Type A; D002462:Cell Membrane; D007672:Kidney Cortex / Q000502:physiology*; D008565:Membrane Proteins / Q000494:pharmacology; D009419:Nerve Tissue Proteins / Q000494:pharmacology*; D009865:Oocytes; D011188:Potassium / Q000493:pharmacokinetics*; D015221:Potassium Channels / Q000502:physiology*; D024661:Potassium Channels, Inwardly Rectifying / Q000502:physiology*; D050683:R-SNARE Proteins; D050827:Syntaxin 1; D014982:Xenopus laevis
D000954:Antigens, Surface; D008565:Membrane Proteins; D009419:Nerve Tissue Proteins; D015221:Potassium Channels; D024661:Potassium Channels, Inwardly Rectifying; D050683:R-SNARE Proteins; D050827:Syntaxin 1; C096323:rimabotulinumtoxinB; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A; C096324:botulinum toxin type C; D011188:Potassium